HLN

Haleon plc

HLN, USA

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

https://www.haleon.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
HLN
stock
HLN

Haleon (NYSE: HLN) sets new chair role, senior director and pay terms details Stock Titan

Read more →
HLN
stock
HLN

Haleon PLC Announces Leadership Changes in Board and Committees TipRanks

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-06-30)

Rating:

BUY

Target Price:

$11.61

Analyst Picks

Strong Buy

2

Buy

2

Hold

0

Sell

1

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-06-30)

Health Score

Price to Earnings Ratio (P/E)

-

High

22.23

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

2.71

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

2.53 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

1.27 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

16.99 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

0.99

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 15.06% of the total shares of Haleon plc

1.

Dodge & Cox

(3.4724%)

since

2025/06/30

2.

Dodge & Cox Stock I

(2.5114%)

since

2025/06/30

3.

FMR Inc

(2.4961%)

since

2025/06/30

4.

ClearBridge Advisors, LLC

(0.7023%)

since

2025/06/30

5.

Harding Loevner L.P.

(0.5037%)

since

2025/06/30

6.

Morgan Stanley - Brokerage Accounts

(0.3961%)

since

2025/06/30

7.

Wellington Management Company LLP

(0.3727%)

since

2025/06/30

8.

Fidelity Series Large Cap Stock

(0.309%)

since

2025/07/31

9.

Bank of America Corp

(0.2766%)

since

2025/06/30

10.

Dodge & Cox Balanced Composite

(0.2701%)

since

2025/06/30

11.

Dodge & Cox Balanced I

(0.2701%)

since

2025/06/30

12.

Strategic Advisers Fidelity US TtlStk

(0.2519%)

since

2025/07/31

13.

OZ Management LLC

(0.2222%)

since

2025/06/30

14.

Fidelity Growth & Income

(0.1966%)

since

2025/07/31

15.

JPMorgan Chase & Co

(0.196%)

since

2025/06/30

16.

Aristotle Capital Management LLC

(0.183%)

since

2025/06/30

17.

Douglas Lane & Associates, LLC

(0.1826%)

since

2025/06/30

18.

Altshuler Shaham Ltd

(0.1773%)

since

2025/06/30

19.

Envestnet Asset Management Inc

(0.1755%)

since

2025/06/30

20.

Renaissance Technologies Corp

(0.1739%)

since

2025/06/30

21.

Goldman Sachs Group Inc

(0.1733%)

since

2025/06/30

22.

VOLORIDGE INVESTMENT MANAGEMENT, LLC

(0.1578%)

since

2025/06/30

23.

Rockefeller Capital Management L.P.

(0.147%)

since

2025/06/30

24.

BlackRock Inc

(0.1435%)

since

2025/06/30

25.

UBS Group AG

(0.1367%)

since

2025/06/30

26.

Nuveen, LLC

(0.1282%)

since

2025/06/30

27.

Hartford Dividend and Growth Y

(0.1274%)

since

2025/07/31

28.

Fidelity Large Cap Stock

(0.0808%)

since

2025/07/31

29.

ClearBridge Large Cap Value I

(0.0801%)

since

2025/07/31

30.

ClearBridge Large Cap Value

(0.0801%)

since

2025/07/31

31.

Fidelity Advisor Capital Development O

(0.0779%)

since

2025/07/31

32.

Dodge & Cox Worldwide US Stock A EUR

(0.0557%)

since

2025/06/30

33.

CREF Stock R3

(0.0506%)

since

2025/07/31

34.

Fidelity Mega Cap Stock

(0.0484%)

since

2025/07/31

35.

VanEck Pharmaceutical ETF

(0.0484%)

since

2025/08/30

36.

Desjardins American Equity Value A

(0.0474%)

since

2025/08/31

37.

Fidelity VIP Growth & Income Initial

(0.0394%)

since

2025/07/31

38.

Touchstone Non-US Equity A

(0.0362%)

since

2025/06/30

39.

AST Large-Cap Value Portfolio

(0.0355%)

since

2025/07/31

40.

Pacific Select Large-Cap Value I

(0.0285%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.1137

Latest Release

Date

2025-09-30

EPS Actual

0.1158

EPS Estimate

0.1261

EPS Difference

-0.0103

Surprise Percent

-8.1681%

Investing Fit Scorecard

(Last Updated 2025-06-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Moderately Defensive(5.5)
Dividend
Decent Dividend Payer(3.5)
Economic Moat
Wide Moat Company(8.3)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(3)
Momentum
Strong Momentum(6.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
High Quality(7)
Value
Fair Value(5.5)

Income Statement

(Last Updated 2025-06-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-06-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-06-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

Haleon plc (HLN) Stock Details & Analysis - Finnton | Finnton